Related Experiment Video
Updated: Aug 8, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Linezolid-resistant Staphylococcus aureus in two pediatric patients receiving low-dose linezolid therapy
Susanne M Roberts1, Alexandra F Freeman, Susan M Harrington
1Department of Laboratory Medicine, Clinical Center, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD 20892, USA.
Abstract:
We report 2 sisters with hyper-IgE syndrome treated with daily suppressive dosages of linezolid (LZD) who developed LZD-resistant Staphylococcus aureus carrying the G2576T mutation in the 23S rRNA gene. Molecular typing suggested transmission of the resistant strain from one sister to the other. LZD-susceptible S. aureus was isolated 2 months after LZD discontinuation. LZD-resistant S. aureus remains rare but may occur while receiving suppressive therapy.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Acute Pyelonephritis II: Diagnostic Studies and Management
Staphylococcal Skin Infections
Drug Dosing: Infants and Children
Antimicrobial Effectiveness

